Cancer-Related Mutations Identified in Primed Human Pluripotent Stem Cells

Yishai Avior, Elyad Lezmi, Kevin Eggan, Nissim Benvenisty*

*Corresponding author for this work

Research output: Contribution to journalLetterpeer-review

20 Scopus citations
Original languageAmerican English
Pages (from-to)10-11
Number of pages2
JournalCell Stem Cell
Volume28
Issue number1
DOIs
StatePublished - 7 Jan 2021

Bibliographical note

Funding Information:
N.B. is the Herbert Cohn Chair in Cancer Research. This work was partially supported by the US-Israel Binational Science Foundation (grant no. 2015089), the Israel Science Foundation (grant no. 494/17), The Rosetrees Trust, and the Azrieli Foundation (to N.B.). Y.A. and N.B. designed the original research. K.E. supplied the reference whole-exome sequencing. Y.A. established the bioinformatical pipeline and performed the original analysis. E.L and Y.A. reanalyzed the data and revised the pipeline. Y.A. E.L. and N.B. interpreted the results and together with K.E. prepared the manuscript. N.B. supervised the study and secured funding. N.B. is CSO of NewStem Ltd. K.E. is a founder of Q-State Biosciences, Quralis, and Enclear Therapies.

Funding Information:
N.B. is the Herbert Cohn Chair in Cancer Research. This work was partially supported by the US-Israel Binational Science Foundation (grant no. 2015089 ), the Israel Science Foundation (grant no. 494/17 ), The Rosetrees Trust , and the Azrieli Foundation (to N.B.).

Cite this